Clinical Trial Update: Study of Romosozumab (AMG 785) Administered to Healthy Participants and Patients With Stage 4 Renal Impairment or Stage 5 Renal Impairment Requiring Hemodialysis [Phase 1]

View source ↗

Summary

Phase 1 trial of romosozumab in healthy participants and in patients with severe renal impairment (hemodialysis) completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Romosozumab (romosozumab)

Snippet

Sponsor: Amgen | Conditions: Osteoporosis | Phase 1 | Status: COMPLETED | Results posted: 2019-02-25